Obesity
Showing NaN - NaN of 36
Obesity, Cardiovascular Diseases Trial in Worldwide (Retatrutide, Placebo)
Not yet recruiting
- Obesity
- Cardiovascular Diseases
- Retatrutide
- Placebo
-
Phoenix, Arizona
- +165 more
May 22, 2023
Overweight, Obesity and Diabetes, Type 2 Trial (Cagrilintide, Semaglutide, Placebo cagrilintide)
Not yet recruiting
- Overweight
- +2 more
- Cagrilintide
- +3 more
-
Concord, California
- +147 more
Jan 24, 2023
Obesity Trial in Worldwide (semaglutide 2.4 mg, semaglutide 2.4 mg ())
Active, not recruiting
- Obesity
- semaglutide 2.4 mg
- semaglutide 2.4 mg (placebo)
-
Montgomery, Alabama
- +64 more
Jan 24, 2023
Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Active, not recruiting
- Overweight
- Obesity
- Semaglutide
- Placebo (semaglutide)
-
Birmingham, Alabama
- +804 more
Dec 19, 2022
Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- liraglutide
- placebo
-
Santa Monica, California
- +31 more
Nov 18, 2022
Obesity Trial in Worldwide (Side-to-side anastomosis duodeno-ileostomy diversion procedure)
Recruiting
- Obesity
- Side-to-side anastomosis duodeno-ileostomy diversion procedure
-
Brussels, Belgium
- +4 more
Apr 4, 2022
Adipose Tissue Pre and Post Bariatric Surgery
Active, not recruiting
- Obesity
- Bariatric surgery
- +7 more
-
Montreal, Quebec, CanadaInstitut de recherches cliniques de Montréal
Mar 22, 2022
Obesity Trial in Montréal (Dyadic health behaviour change intervention, Dyadic nutrition counselling intervention)
Active, not recruiting
- Obesity
- Dyadic health behaviour change intervention
- Dyadic nutrition counselling intervention
-
Montréal, Quebec, CanadaConcordia University
Mar 15, 2022
Obesity Trial in Worldwide (Semaglutide 2.4 mg, Placebo)
Active, not recruiting
- Obesity
- Semaglutide 2.4 mg
- Placebo
-
Calgary, Alberta, Canada
- +21 more
Mar 22, 2022
Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (Semaglutide))
Completed
- Overweight
- Obesity
- Semaglutide
- Placebo (Semaglutide)
-
Birmingham, Alabama
- +40 more
Mar 21, 2022
Overweight, Obesity Trial in Montreal (NNC0174-0833, Oral contraceptive (OC) tablets, Acetaminophen)
Completed
- Overweight
- Obesity
- NNC0174-0833
- +2 more
-
Montreal, Quebec, CanadaNovo Nordisk Investigational Site
Jan 6, 2022
Nutritional Disorders, Obesity, Development Trial in Toronto, Montreal
Recruiting
- Nutritional Disorders
- +2 more
-
Toronto, Ontario, Canada
- +2 more
Nov 9, 2021
Obesity, Overweight Trial in Worldwide (Semaglutide 1.0 mg, Semaglutide 2.4 mg, Placebo I (Semaglutide))
Completed
- Obesity
- Overweight
- Semaglutide 1.0 mg
- +3 more
-
Buena Park, California
- +146 more
Nov 8, 2021
Bone and Muscle Quality and Strength in Obesity With and Without
Completed
- Diabetes Mellitus
- +10 more
-
Montréal, Quebec, Canada
- +1 more
Aug 30, 2021
Sarcopenia, Obesity Trial in Montreal (dietary supplement, other, behavioral)
Completed
- Sarcopenia
- Obesity
- Citrulline
- +3 more
-
Montreal, Quebec, CanadaUniversite du Quebec a Montreal
Aug 3, 2021
Overeating, Overweight, Obesity Trial in Montréal (Brief mindful eating intervention)
Completed
- Overeating
- +2 more
- Brief mindful eating intervention
-
Montréal, Quebec, CanadaMcGill University
Aug 26, 2020
Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (semaglutide, liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- semaglutide
- +2 more
-
Anaheim, California
- +73 more
Apr 14, 2020
Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)
Completed
- Cardiovascular Disease
- +4 more
- Lorcaserin hydrochloride
- Placebo
-
Alexander City, Alabama
- +498 more
Jun 27, 2019
Adenomatous Polyp, Colorectal Cancer, Obesity Trial in Canada, United States (metformin HCl)
Completed
- Adenomatous Polyp
- +2 more
- metformin hydrochloride
-
Long Beach, California
- +3 more
Feb 14, 2019
Overweight, Obesity Trial in Montreal (Enriched GLB, Standard GLB)
Completed
- Overweight
- Obesity
- Enriched GLB
- Standard GLB
-
Montreal, Quebec, CanadaMcGill University
Mar 20, 2018
Does Treating Obstructive Sleep Apnea in Obese Canadian Youth
Completed
- Obesity
- Obstructive Sleep Apnea
-
Calgary, Alberta, Canada
- +3 more
Mar 7, 2018
Metabolism and Nutrition Disorder, Obesity Trial in Canada, United States (liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- liraglutide
- placebo
-
Goodyear, Arizona
- +36 more
Sep 29, 2017